Gene · 2202
Papers1,739
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 1,739
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Molecular Determinants of Chronic Venous Disease: A Comprehensive Review. | Int J Mol Sci | 2023 | 36768250 | PubTator, text mining | PubMed |
| Identification of Highly Sensitive Pleural Effusion Protein Biomarkers for Malignant Pleural Mesothelioma by Affinity-Based Quantitative Proteomics. | Cancers (Basel) | 2023 | 36765599 | PubTator, text mining | PubMed |
| Transcriptomic profiling analysis of human endometrial stromal cells treated with autologous platelet-rich plasma. | Reprod Med Biol | 2023 | 36704119 | PubTator, text mining | PubMed |
| Origin, prospective identification, and function of circulating endothelial colony-forming cells in mice and humans. | JCI Insight | 2023 | 36692963 | PubTator, text mining | PubMed |
| Functional Relationships between Long Non-Coding RNAs and Estrogen Receptor Alpha: A New Frontier in Hormone-Responsive Breast Cancer Management. | Int J Mol Sci | 2023 | 36674656 | PubTator, text mining | PubMed |
| Clinical and Biological Significances of FBLN5 in Gastric Cancer. | Cancers (Basel) | 2023 | 36672502 | PubTator, text mining | PubMed |
| BAP1 Loss Is Associated with Higher ASS1 Expression in Epithelioid Mesothelioma: Implications for Therapeutic Stratification. | Mol Cancer Res | 2023 | 36669126 | PubTator, text mining | PubMed |
| The Need for Biomarkers in the ALS-FTD Spectrum: A Clinical Point of View on the Role of Proteomics. | Proteomes | 2023 | 36648959 | PubTator, text mining | PubMed |
| Comparative study of differentiating human pluripotent stem cells into vascular smooth muscle cells in hydrogel-based culture methods. | Regen Ther | 2023 | 36618488 | PubTator, text mining | PubMed |
| Regional and disease specific human lung extracellular matrix composition. | Biomaterials | 2023 | 36580718 | PubTator, text mining | PubMed |
| Comparison of Proteomic Measurements Across Platforms in the Atherosclerosis Risk in Communities (ARIC) Study. | Clin Chem | 2023 | 36508319 | PubTator, text mining | PubMed |
| Vascular smooth muscle cell senescence accelerates medin aggregation via small extracellular vesicle secretion and extracellular matrix reorganization. | Aging Cell | 2023 | 36433666 | PubTator, text mining | PubMed |
| Distinct Phenotypic Consequences of Pathogenic Mutants Associated with Late-Onset Retinal Degeneration. | Am J Pathol | 2023 | 36328299 | PubTator, text mining | PubMed |
| Loss of bone morphogenetic protein signaling in fibroblasts results in CXCL12-driven serrated polyp development. | J Gastroenterol | 2023 | 36326956 | PubTator, text mining | PubMed |
| Pathophysiology of cellulite: Possible involvement of selective endotoxemia. | Obes Rev | 2023 | 36285892 | PubTator, text mining | PubMed |
| The Diagnostic and Prognostic Significance of EFEMP1 in Breast Cancer: An Immunohistochemistry Study. | Int J Surg Pathol | 2023 | 36259327 | PubTator, text mining | PubMed |
Prevention of sarcopenia in patients with obesity after bariatric and metabolic surgery: The effect of programmed training on the muscle tissue and anthropometric functions - A randomized controlled trial (SarxOb study protocol). | Biomol Biomed | 2023 | 36154873 | PubTator, text mining | PubMed |
| In Vitro and In Vivo Comparative Analysis of Differentially Expressed Genes and Signaling Pathways in Breast Cancer Cells on Interaction with Mesenchymal Stem Cells. | Appl Biochem Biotechnol | 2023 | 36087230 | PubTator, text mining | PubMed |
| Association of EFEMP1 with juvenile-onset open angle glaucoma in a patient with concomitant COL11A1-related Stickler syndrome. | Ophthalmic Genet | 2023 | 35946471 | PubTator, text mining | PubMed |
| Complement factor B is critical for sub-RPE deposit accumulation in a model of Doyne honeycomb retinal dystrophy with features of age-related macular degeneration. | Hum Mol Genet | 2023 | 35943778 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2202/papers?page=16